Improving compliance in your dyslipidemic patient: an evidence-based approach.
OBJECTIVE
To synthesize the evidence from landmark clinical studies of lipid-lowering pharmacotherapy and nurse management of hyperlipidemia, discuss issues related to nonadherence, and proposes strategies for achieving long-term cholesterol control.


METHODS
All publications of lipid-lowering clinical trials related to pharmacotherapy for dyslipidemias were accessed from a thorough Medline Search and reviewed by two nurse experts.


CONCLUSIONS
Randomized controlled studies provide compelling evidence that reduction of blood cholesterol with pharmacotherapy reduces both first and subsequent coronary events. Nonetheless, inadequate provider and patient adherence to guidelines for lipid lowering remains prevalent. Studies show that nurses provide safe and effective care for patients with abnormal lipids.


CONCLUSIONS
This article assists nurse practitioners in playing an active role in the implementation of the National Cholesterol Education Program Adult Treatment Panel III Report to be released in Spring 2001, where a strong emphasis will be placed on multidisciplinary approaches and adherence.
Becker
D M
DM
Center for Health Promotion, Johns Hopkins University School of Medicine, USA. dbecker607@aol.com
Allen
J K
JK
D002986:Clinical Trials as Topic; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000451:nursing*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009732:Nursing Care / Q000592:standards; D010349:Patient Compliance; D017410:Practice Guidelines as Topic
D000960:Hypolipidemic Agents